Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer

Recruiting now

Conditions studied: Colorectal Cancer

In brief

This study aims to evaluate the survival and treatment outcomes among colorectal cancer patients undergoing anti-cancer treatment, both with and without an immunomodulator.

Key facts

Study ID

NCT06557668

Run by

Taichung Veterans General Hospital

People needed

250

Starts

2024-08-20

Expected to finish

2026-07-01

Last updated by the study team

2026-01-29

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 20 years and older.
• Patients who have been given a diagnosis of colorectal cancer.
• Patients had previously initiated anti-cancer therapies between January 1, 2020, and Apr 30, 2024.

You may not qualify if…

• None

Where it is running

• Taichung Veterans General Hospital — Taichung, Taiwan (enrolling)
• Chung-Shan Medical University Hospital — Taichung, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.